Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

The Global Biologic Therapeutics Market 2018-2022; Dominated by AbbVie, Johnson & Johnson, Merck, and Pfizer - ResearchAndMarkets.com

Research and Markets
Posted on: 09 Jan 19

The "Global Biologic Therapeutics Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

The biologic therapeutics market will register a CAGR of over 11% by 2022.

Increasing incidence of chronic diseases and immunological disorders to drive growth in the market

Biologics are ideal for the treatment of chronic disorders including cancer, autoimmune disorders, hormonal deficiencies, neurological disorders, and other critical conditions.

The incidence of these diseases is rising significantly in developed nations. The increase in aging population and the lifestyle of people in these countries is responsible for the rise in occurrence of cancer, immunological disorders, and other chronic ailments.

Increasing investment in development of biologics

Biotechnological products help manufacturers to earn huge revenues because of the therapeutic benefits they provide. Thus, many pharmaceutical companies are moving toward the development of biologics.

Reimbursement challenges of new biologics

The reimbursements available for biologics are very limited compared with that available for conventional therapeutics, despite the high costs. Manufacturers are providing biologics with mandatory companion diagnostics, which increases the overall cost of that biologic, making it difficult for insurers to provide reimbursements.

Key Players

  • AbbVie
  • Johnson & Johnson
  • Merck
  • Pfizer

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

PART 05: PIPELINE ANALYSIS

PART 06: MARKET SIZING

PART 07: FIVE FORCES ANALYSIS

PART 08: MARKET SEGMENTATION BY TYPE OF THERAPEUTIC AGENT

  • Segmentation by therapeutic agent
  • Comparison by therapeutic agent
  • Monoclonal antibodies - Market size and forecast 2017-2022
  • Others - Market size and forecast 2017-2022
  • Vaccines - Market size and forecast 2017-2022
  • Cell and tissue-based therapy - Market size and forecast 2017-2022
  • Gene therapy - Market size and forecast 2017-2022
  • Market opportunity by therapeutic agent

PART 09: MARKET SEGMENTATION BY APPLICATION

  • Oncology
  • Autoimmune and inflammatory diseases
  • Hematology
  • Others

PART 10: CUSTOMER LANDSCAPE

PART 11: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Americas - Market size and forecast 2017-2022
  • EMEA - Market size and forecast 2017-2022
  • APAC - Market size and forecast 2017-2022
  • Market opportunity

PART 12: DECISION FRAMEWORK

PART 13: DRIVERS AND CHALLENGES

PART 14: MARKET TRENDS

PART 15: VENDOR LANDSCAPE

PART 16: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • AbbVie
  • Johnson & Johnson
  • Merck
  • Pfizer

For more information about this report visit https://www.researchandmarkets.com/research/fkjkh8/the_global?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190109005474/en/

Business Wire
www.businesswire.com

Last updated on: 09/01/2019

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.